Study Of Perennial Allergic Rhinitis

GlaxoSmithKline65 enrolled

Overview

This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Rhinitis, Allergic, Seasonal

Interventions

GW685698DRUG

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

Inclusion criteria: * Informed consent. * Outpatient. * Diagnosis of perennial allergic rhinitis with symptoms. * Able to comply with study procedures. Exclusion criteria: * Significant concomitant medical condition. * Use of corticosteroids/allergy medications. * Laboratory abnormality. * Positive pregnancy test.

Locations (1)

GSK Investigational Site

Outcomes

Primary Outcomes

Adverse events and laboratory blood test

Secondary Outcomes

Change of nasal symptom score

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.